603811 诚意药业
已收盘 11-06 15:00:00
资讯
新帖
简况
股市必读：诚意药业（603811）11月3日董秘有最新回复
证券之星 · 11-04 04:38
股市必读：诚意药业（603811）11月3日董秘有最新回复
诚意药业（603811）2026年三季报简析：增收不增利
证券之星 · 10-31
诚意药业（603811）2026年三季报简析：增收不增利
诚意药业（603811）10月30日主力资金净买入377.98万元
证券之星 · 10-30
诚意药业（603811）10月30日主力资金净买入377.98万元
诚意药业(603811)9月30日股东户数2.34万户，较上期增加12.77%
证券之星 · 10-28
诚意药业(603811)9月30日股东户数2.34万户，较上期增加12.77%
图解诚意药业三季报：第三季度单季净利润同比增长38.27%
证券之星 · 10-28
图解诚意药业三季报：第三季度单季净利润同比增长38.27%
诚意药业(603811.SH)发布前三季度业绩，归母净利润1.37亿元，同比下降4.17%
智通财经 · 10-28
诚意药业(603811.SH)发布前三季度业绩，归母净利润1.37亿元，同比下降4.17%
股市必读：诚意药业新发布《浙江诚意药业股份有限公司董事、高级管理人员减持股份结果公告》
证券之星 · 10-26
股市必读：诚意药业新发布《浙江诚意药业股份有限公司董事、高级管理人员减持股份结果公告》
股市必读：诚意药业新发布《浙江诚意药业股份有限公司董事、高级管理人员减持股份结果公告》
证券之星 · 10-23
股市必读：诚意药业新发布《浙江诚意药业股份有限公司董事、高级管理人员减持股份结果公告》
诚意药业：10月9日董事张志宏减持股份合计30万股
证券之星 · 10-13
诚意药业：10月9日董事张志宏减持股份合计30万股
诚意药业（603811）披露高级管理人员减持股份结果公告，9月30日股价上涨0.58%
证券之星 · 09-30
诚意药业（603811）披露高级管理人员减持股份结果公告，9月30日股价上涨0.58%
诚意药业：9月24日至9月28日高级管理人员吕孙战减持股份合计27万股
证券之星 · 09-29
诚意药业：9月24日至9月28日高级管理人员吕孙战减持股份合计27万股
诚意药业（603811）披露子公司收到药品GMP符合性检查结果公告，9月28日股价上涨0.29%
证券之星 · 09-28
诚意药业（603811）披露子公司收到药品GMP符合性检查结果公告，9月28日股价上涨0.29%
诚意药业(603811.SH)子公司福建华康获得药品GMP符合性检查结果
智通财经 · 09-28
诚意药业(603811.SH)子公司福建华康获得药品GMP符合性检查结果
每周股票复盘：诚意药业（603811）将召开2026年半年度业绩说明会
证券之星 · 09-13
每周股票复盘：诚意药业（603811）将召开2026年半年度业绩说明会
诚意药业（603811）披露2026年半年度业绩说明会公告，9月10日股价下跌1.53%
证券之星 · 09-10
诚意药业（603811）披露2026年半年度业绩说明会公告，9月10日股价下跌1.53%
每周股票复盘：诚意药业（603811）股东户数降13.57%
证券之星 · 08-30
每周股票复盘：诚意药业（603811）股东户数降13.57%
股市必读：诚意药业新发布《浙江诚意药业股份有限公司2026年半年度主要经营数据的公告》
证券之星 · 08-28
股市必读：诚意药业新发布《浙江诚意药业股份有限公司2026年半年度主要经营数据的公告》
诚意药业（603811）2026年中报简析：增收不增利
证券之星 · 08-28
诚意药业（603811）2026年中报简析：增收不增利
股市必读：诚意药业中报 - 第二季度单季净利润同比下降24.09%
证券之星 · 08-27
股市必读：诚意药业中报 - 第二季度单季净利润同比下降24.09%
诚意药业(603811.SH)发布半年度业绩，归母净利润9487万元，同比下降15.61%
智通财经 · 08-26
诚意药业(603811.SH)发布半年度业绩，归母净利润9487万元，同比下降15.61%
加载更多
公司概况
公司名称：
浙江诚意药业股份有限公司
所属行业：
医药制造业
上市日期：
2017-03-15
主营业务：
浙江诚意药业股份有限公司的主营业务是制剂及原料药的研发、生产和销售。公司的主要产品是关节类、利尿降压类、抗病毒类、抗肿瘤类、安神补脑类。公司曾获评温州市长质量奖、浙江省工业行业“平安企业”建设优秀单位等荣誉。
发行价格：
15.76
{"stockData":{"symbol":"603811","market":"SH","secType":"STK","nameCN":"诚意药业","latestPrice":6.73,"timestamp":1793948400000,"preClose":6.78,"halted":0,"volume":3966302,"delay":0,"changeRate":-0.0074,"floatShares":458000000,"shares":458000000,"eps":0.4129,"marketStatus":"已收盘","change":-0.05,"latestTime":"11-06 15:00:00","open":6.7,"high":6.79,"low":6.63,"amount":26651400,"amplitude":0.0236,"askPrice":6.73,"askSize":21,"bidPrice":6.72,"bidSize":20,"shortable":0,"etf":0,"ttmEps":0.4129,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":5,"adr":0,"adjPreClose":6.78,"symbolType":"stock","openAndCloseTimeList":[[1793928600000,1793935800000],[1793941200000,1793948400000]],"highLimit":7.46,"lowLimit":6.1,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":458226048,"isCdr":false,"pbRate":2.07,"roa":"--","peRate":16.299346,"roe":"9.52%","epsLYR":0.61,"committee":0.326541,"marketValue":3084000000,"turnoverRate":0.0087,"status":1,"floatMarketCap":3084000000},"requestUrl":"/m/hq/s/603811","defaultTab":"news","newsList":[{"id":"2680425774","title":"股市必读：诚意药业（603811）11月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2680425774","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680425774?lang=zh_cn&edition=full","pubTime":"2026-11-04 04:38","pubTimestamp":1793738293,"startTime":"0","endTime":"0","summary":"截至2026年11月3日收盘，诚意药业报收于6.76元，下跌0.59%，换手率1.13%，成交量5.17万手，成交额3505.34万元。董秘最新回复投资者： 董秘您好！关注到公司从事化学原料药及制剂研发生产。根据《科技伦理审查办法（试行）》的规定，本公司所开展的化学原料药及制剂研发活动，若涉及人体研究、人类生物样本或实验动物等情形，均属于该办法规定的科技伦理审查范围。当日关注点交易信息汇总：11月3日主力资金净流出57.16万元，占总成交额1.63%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400006521.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603811"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679251782","title":"诚意药业（603811）2026年三季报简析：增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2679251782","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679251782?lang=zh_cn&edition=full","pubTime":"2026-10-31 07:33","pubTimestamp":1793403194,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期诚意药业发布2026年三季报。根据财报显示，诚意药业增收不增利。其中，毛利率71.2%，同比增0.34%，净利率22.48%，同比减7.19%，销售费用、管理费用、财务费用总计2.6亿元，三费占营收比42.31%，同比增4.48%，每股净资产3.26元，同比减19.4%，每股经营性现金流0.4元，同比减33.29%，每股收益0.3元，同比减6.25%证券之星价投圈财报分析工具显示：业务评价：公司去年的ROIC为13.72%，资本回报率强。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100016231.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603811","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679623142","title":"诚意药业（603811）10月30日主力资金净买入377.98万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2679623142","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679623142?lang=zh_cn&edition=full","pubTime":"2026-10-30 15:24","pubTimestamp":1793345052,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月30日收盘，诚意药业报收于6.69元，上涨1.36%，换手率2.01%，成交量9.21万手，成交额6183.13万元。10月30日的资金流向数据方面，主力资金净流入377.98万元，占总成交额6.11%，游资资金净流入70.62万元，占总成交额1.14%，散户资金净流出448.59万元，占总成交额7.26%。诚意药业主营业务：化学药品原料药及制剂的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000033120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603811"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678463789","title":"诚意药业(603811)9月30日股东户数2.34万户，较上期增加12.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678463789","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678463789?lang=zh_cn&edition=full","pubTime":"2026-10-28 18:32","pubTimestamp":1793183534,"startTime":"0","endTime":"0","summary":"证券之星消息，近日诚意药业披露，截至2026年9月30日公司股东户数为2.34万户，较6月30日增加2645.0户，增幅为12.77%。在化学制药行业个股中，诚意药业股东户数低于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.9万户。从股价来看，2026年6月30日至2026年9月30日，诚意药业区间跌幅为7.05%，在此期间股东户数增加2645.0户，增幅为12.77%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800040105.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603811"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678450505","title":"图解诚意药业三季报：第三季度单季净利润同比增长38.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678450505","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678450505?lang=zh_cn&edition=full","pubTime":"2026-10-28 17:55","pubTimestamp":1793181316,"startTime":"0","endTime":"0","summary":"证券之星消息，诚意药业2026年三季报显示，前三季度公司主营收入6.14亿元，同比上升2.87%；归母净利润1.37亿元，同比下降4.17%；扣非净利润1.23亿元，同比下降12.63%；其中2026年第三季度，公司单季度主营收入1.82亿元，同比上升1.13%；单季度归母净利润4189.63万元，同比上升38.27%；单季度扣非净利润3020.92万元，同比上升3.32%；负债率15.47%，投资收益1505.11万元，财务费用49.82万元，毛利率71.2%。财报数据概要请见下图:本文数据来源于诚意药业2026年三季报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800038905.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603811"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678452276","title":"诚意药业(603811.SH)发布前三季度业绩，归母净利润1.37亿元，同比下降4.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2678452276","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678452276?lang=zh_cn&edition=full","pubTime":"2026-10-28 17:27","pubTimestamp":1793179664,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诚意药业(603811.SH)披露2026年第三季度报告，前三季度公司实现营业收入6.14亿元，同比增长2.87%;归母净利润1.37亿元，同比下降4.17%;扣非净利润1.23亿元，同比下降12.63%;基本每股收益0.30元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1514247.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603811"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678348501","title":"股市必读：诚意药业新发布《浙江诚意药业股份有限公司董事、高级管理人员减持股份结果公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2678348501","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678348501?lang=zh_cn&edition=full","pubTime":"2026-10-26 07:05","pubTimestamp":1792969516,"startTime":"0","endTime":"0","summary":"截至2026年10月23日收盘，诚意药业报收于6.63元，上涨1.07%，换手率1.03%，成交量4.72万手，成交额3076.7万元。当日关注点交易信息汇总：10月23日主力资金净流出118.97万元，占总成交额3.87%。公司公告汇总：董事张志宏减持计划期满，实际减持400,000股，减持总金额2,816,000元，未完成部分406,736股。公司公告汇总浙江诚意药业股份有限公司董事、高级管理人员减持股份结果公告本次减持计划实施前，张志宏持有公司3,226,944股，占总股本0.70%；截至公告日，持有2,826,944股，占总股本0.62%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102600001745.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603811","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677992378","title":"股市必读：诚意药业新发布《浙江诚意药业股份有限公司董事、高级管理人员减持股份结果公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2677992378","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677992378?lang=zh_cn&edition=full","pubTime":"2026-10-23 05:24","pubTimestamp":1792704256,"startTime":"0","endTime":"0","summary":"公司公告汇总：张志宏减持计划期满，实际减持400,000股、金额281.6万元，未完成部分406,736股，减持行为合规并已披露。公司公告汇总浙江诚意药业股份有限公司董事、高级管理人员减持股份结果公告本次减持计划实施前，张志宏先生持有公司3,226,944股，占总股本0.70%；截至公告日，其持有2,826,944股，占总股本0.62%。2026年7月1日，公司披露张志宏拟于2026年7月23日至10月22日期间通过集中竞价方式减持不超过806,736股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300004703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603811"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675516663","title":"诚意药业：10月9日董事张志宏减持股份合计30万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2675516663","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675516663?lang=zh_cn&edition=full","pubTime":"2026-10-13 20:01","pubTimestamp":1791892908,"startTime":"0","endTime":"0","summary":"证券之星消息，根据10月13日市场公开信息、上市公司公告及交易所披露数据整理，诚意药业（603811）最新董监高及相关人员股份变动情况：2026年10月9日公司董事,高级管理人员张志宏共减持公司股份30.0万股，占公司总股本为0.0655%。变动期间公司股价上涨2.17%，10月9日当日收盘报7.07元。诚意药业近半年内的董监高及核心技术人员增减持详情如下：诚意药业的高管列表及最新持股情况如下：该股最近90天内无机构评级。本文数据来源于上海证券交易所信息披露、诚意药业公告，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300035601.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603811","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671788490","title":"诚意药业（603811）披露高级管理人员减持股份结果公告，9月30日股价上涨0.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2671788490","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671788490?lang=zh_cn&edition=full","pubTime":"2026-09-30 22:24","pubTimestamp":1790778259,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘，诚意药业报收于6.99元，较前一交易日上涨0.58%，最新总市值为32.03亿元。近日，诚意药业发布《高级管理人员减持股份结果公告》。截至2026年9月30日，吕孙战已减持453,789股，减持价格区间为6.87至7.02元/股，减持总金额3,149,021.44元，本次减持计划已实施完毕。减持后吕孙战持有公司股份1,361,367股，占总股本0.30%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000038091.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603811","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671221123","title":"诚意药业：9月24日至9月28日高级管理人员吕孙战减持股份合计27万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2671221123","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671221123?lang=zh_cn&edition=full","pubTime":"2026-09-29 20:01","pubTimestamp":1790683299,"startTime":"0","endTime":"0","summary":"证券之星消息，根据9月29日市场公开信息、上市公司公告及交易所披露数据整理，诚意药业（603811）最新董监高及相关人员股份变动情况：2026年9月24日至2026年9月28日公司高级管理人员吕孙战共减持公司股份27.0万股，占公司总股本为0.0589%。变动期间公司股价下跌1.01%，9月28日当日收盘报6.89元。诚意药业近半年内的董监高及核心技术人员增减持详情如下：诚意药业的高管列表及最新持股情况如下：该股最近90天内无机构评级。本文数据来源于上海证券交易所信息披露、诚意药业公告，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900035648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603811"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670551822","title":"诚意药业（603811）披露子公司收到药品GMP符合性检查结果公告，9月28日股价上涨0.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670551822","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670551822?lang=zh_cn&edition=full","pubTime":"2026-09-28 22:37","pubTimestamp":1790606238,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘，诚意药业报收于6.89元，较前一交易日上涨0.29%，最新总市值为31.57亿元。该股当日开盘6.9元，最高6.97元，最低6.86元，成交额达2801.03万元，换手率为0.88%。近日，浙江诚意药业股份有限公司发布《关于子公司收到药品GMP符合性检查结果的公告》。该生产线年设计产能为2000吨，主要生产盐酸氨基葡萄糖原料药，用于治疗和预防骨关节炎。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800035327.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603811","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670121282","title":"诚意药业(603811.SH)子公司福建华康获得药品GMP符合性检查结果","url":"https://stock-news.laohu8.com/highlight/detail?id=2670121282","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670121282?lang=zh_cn&edition=full","pubTime":"2026-09-28 15:44","pubTimestamp":1790581449,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诚意药业(603811.SH)发布公告，近日，公司子公司福建华康药业有限公司(以下简称“福建华康”)从福建省药品监督管理局网站获悉药品GMP符合性检查结果(编号：FJSC2026-038)。该企业原料药盐酸氨基葡萄糖(新增B09车间盐酸氨基葡萄糖原料药生产线)生产和质量管理符合《药品生产质量管理规范(2010年修订)》及其附录要求。本次福建华康获得上述药品GMP符合性检查结果，表明福建华康相关生产线符合GMP要求，有利于福建华康继续保证产品质量和持续稳定的生产能力，更好地满足市场需求，对公司未来发展产生积极作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1501407.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"诚意药业(603811.SH)子公司福建华康获得药品GMP符合性检查结果","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603811","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667500541","title":"每周股票复盘：诚意药业（603811）将召开2026年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2667500541","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667500541?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:17","pubTimestamp":1789240630,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，诚意药业报收于6.91元，较上周的7.21元下跌4.16%。本周，诚意药业9月8日盘中最高价报7.32元。本周关注点公司公告汇总：诚意药业将于2026年9月17日召开半年度业绩说明会。公司公告汇总浙江诚意药业股份有限公司将于2026年9月17日上午09:00-10:00在同花顺路演平台举行2026年半年度业绩说明会，介绍公司经营成果和财务状况。说明会结束后可通过同花顺平台查看会议内容。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300000991.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603811","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666518594","title":"诚意药业（603811）披露2026年半年度业绩说明会公告，9月10日股价下跌1.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666518594","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666518594?lang=zh_cn&edition=full","pubTime":"2026-09-10 22:45","pubTimestamp":1789051516,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，诚意药业报收于7.08元，较前一交易日下跌1.53%，最新总市值为32.44亿元。该股当日开盘7.19元，最高7.19元，最低7.02元，成交额达3354.74万元，换手率为1.03%。公告显示，公司将于2026年9月17日上午09:00-10:00在同花顺路演平台举行2026年半年度业绩说明会，介绍公司经营成果和财务状况。参会人员包括董事、总经理赵春建，副总经理罗飞跃，董事、董事会秘书柯泽慧，财务总监吕孙战及独立董事黄明。说明会结束后可通过同花顺平台查看会议内容。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000042613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603811"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663804394","title":"每周股票复盘：诚意药业（603811）股东户数降13.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663804394","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663804394?lang=zh_cn&edition=full","pubTime":"2026-08-30 07:52","pubTimestamp":1788047531,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，诚意药业报收于7.32元，较上周的7.4元下跌1.08%。本周，诚意药业8月26日盘中最高价报7.63元。股本股东变化截至2026年6月30日，诚意药业股东户数为2.07万户，较3月31日减少3252.0户，减幅为13.57%。公司公告汇总诚意药业披露2026年半年度主要经营数据：报告期内，公司实现主营业务收入431,458,584.61元，同比增长3.65%；主营业务成本125,872,992.74元，同比增长0.03%；整体毛利率为70.83%，同比上升1.06个百分点。境内收入同比增长4.36%，境外收入同比下降19.57%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000004045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603811"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662393540","title":"股市必读：诚意药业新发布《浙江诚意药业股份有限公司2026年半年度主要经营数据的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2662393540","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662393540?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:23","pubTimestamp":1787869433,"startTime":"0","endTime":"0","summary":"公司公告汇总浙江诚意药业股份有限公司2026年半年度主要经营数据的公告报告期内，公司实现主营业务收入431,458,584.61元，同比增长3.65%；主营业务成本125,872,992.74元，同比增长0.03%；整体毛利率为70.83%，同比上升1.06个百分点。浙江诚意药业股份有限公司第五届董事会第六次会议决议公告公司于2026年8月25日召开第五届董事会第六次会议，审议通过《2026年半年度报告及摘要》和《关于修订〈董事会秘书工作细则〉的议案》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800011178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603811"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662360170","title":"诚意药业（603811）2026年中报简析：增收不增利","url":"https://stock-news.laohu8.com/highlight/detail?id=2662360170","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662360170?lang=zh_cn&edition=full","pubTime":"2026-08-28 06:14","pubTimestamp":1787868878,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期诚意药业发布2026年中报。根据财报显示，诚意药业增收不增利。截至本报告期末，公司营业总收入4.32亿元，同比上升3.63%，归母净利润9486.87万元，同比下降15.62%。去年的净利率为24.31%，算上全部成本后，公司产品或服务的附加值高。财报体检工具显示：建议关注公司现金流状况本文数据来源于诚意药业2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800010782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603811"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662574745","title":"股市必读：诚意药业中报 - 第二季度单季净利润同比下降24.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662574745","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662574745?lang=zh_cn&edition=full","pubTime":"2026-08-27 05:38","pubTimestamp":1787780294,"startTime":"0","endTime":"0","summary":"公司公告汇总浙江诚意药业股份有限公司2026年半年度主要经营数据的公告报告期内，公司实现主营业务收入431,458,584.61元，同比增长3.65%；主营业务成本125,872,992.74元，同比增长0.03%；整体毛利率为70.83%，同比上升1.06个百分点；制剂收入同比增长11.83%，原料药收入同比下降34.67%；境内收入同比增长4.36%，境外收入同比下降19.57%；食品及其他业务收入波动较大。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700010419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603811"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662792590","title":"诚意药业(603811.SH)发布半年度业绩，归母净利润9487万元，同比下降15.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662792590","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662792590?lang=zh_cn&edition=full","pubTime":"2026-08-26 17:50","pubTimestamp":1787737840,"startTime":"0","endTime":"0","summary":"智通财经APP讯，诚意药业(603811.SH)披露2026年半年度报告，报告期公司实现营业收入4.32亿元，同比增长3.63%;归属于上市公司股东的净利润9487万元，同比下降15.61%;归属于上市公司股东的扣除非经常性损益的净利润9245万元，同比下降16.83%;基本每股收益0.21元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1486091.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603811"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793972318807,"stockEarnings":[{"period":"1week","weight":0.0273},{"period":"1month","weight":-0.03},{"period":"3month","weight":-0.0875},{"period":"6month","weight":-0.2066},{"period":"1year","weight":-0.1722},{"period":"ytd","weight":-0.0705}],"compareEarnings":[{"period":"1week","weight":0.0105},{"period":"1month","weight":-0.0396},{"period":"3month","weight":-0.0635},{"period":"6month","weight":-0.1172},{"period":"1year","weight":-0.0704},{"period":"ytd","weight":-0.0703}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江诚意药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"23358人(较上一季度增加12.77%)","perCapita":"19617股","listingDate":"2017-03-15","address":"浙江省温州市洞头区化工路118号","registeredCapital":"45822万元","survey":" 浙江诚意药业股份有限公司的主营业务是制剂及原料药的研发、生产和销售。公司的主要产品是关节类、利尿降压类、抗病毒类、抗肿瘤类、安神补脑类。公司曾获评温州市长质量奖、浙江省工业行业“平安企业”建设优秀单位等荣誉。","listedPrice":15.76},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诚意药业(603811)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诚意药业(603811)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诚意药业,603811,诚意药业股票,诚意药业股票老虎,诚意药业股票老虎国际,诚意药业行情,诚意药业股票行情,诚意药业股价,诚意药业股市,诚意药业股票价格,诚意药业股票交易,诚意药业股票购买,诚意药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诚意药业(603811)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诚意药业(603811)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}